Genomic Medicine and the Mainstream
How does the ecosystem need to come together to bring the benefits of genomic medicine into the mainstream?
Chris Wigley is the CEO of Genomics England, which exists to push insights from cutting edge genomics data analytics into routine medical care. As the national steward of 40 petabytes of human genome data from 100,000 volunteers, and a unique partnership with the NHS, Genomics England’s goal is to improve patient outcomes while lowering the cost of healthcare provision. Through the COVID crisis Chris was seconded as Senior Responsible Officer for Data to NHSX, and Genomics England launched a major research programme into the genomic drivers of severity of response to COVID.
Parker Moss is Chief Commercial Officer for Genomics England, a Department of Health organisation focussed on driving Genomic Medicine into the NHS, and accelerating Genomic research in industry and academia. Parker is responsible for commercial and academic partnerships with Biopharma, Universities and the life science ecosystem.
Serena Nik-Zainal is a consultant in clinical genetics and Cancer Research UK Advanced Clinician Scientist at the University of Cambridge. She makes use of genomics for clinical applications. She was awarded the Royal Society Francis Crick Medal & Lecture in 2021.
Supported by Amazon Web Services.